POC

Amartus Wins “Service Assurance Implementation” Award for MEF 19 Proof of Concept

Retrieved on: 
Thursday, November 21, 2019

The MEF 3.0 Proof of Concept (PoC) awards recognize leadership and innovation in nine major categories in the MEF 3.0 Proof of Concept Showcase at MEF19.

Key Points: 
  • The MEF 3.0 Proof of Concept (PoC) awards recognize leadership and innovation in nine major categories in the MEF 3.0 Proof of Concept Showcase at MEF19.
  • Amartus was announced as a winner during a special MEF 3.0 PoC awards ceremony on 20 November in the MEF19 Networking Hall.
  • The open, multi-carrier, multi-vendor proof of concept (PoC) showcase was titled Dynamic Connectivity and Commerce Enabled by MEF 3.0 and Blockchain.
  • Amartus has been a MEF member for a decade, actively contributing to MEFs flagship initiatives and it is an honor to be recognized with this award.

Amartus Tackles Complete Life-Cycle Automation for On-Demand Inter-Carrier Connectivity Using MEF Sonata APIs & Blockchain

Retrieved on: 
Tuesday, November 19, 2019

Building on the work of the award-winning MEF 18 Fulfillment & Activation PoC, this MEF 19 PoC adds DLT/Blockchain technologies for automated settlement and billing to complete the negotiation life-cycle.

Key Points: 
  • Building on the work of the award-winning MEF 18 Fulfillment & Activation PoC, this MEF 19 PoC adds DLT/Blockchain technologies for automated settlement and billing to complete the negotiation life-cycle.
  • Cloud and enterprise software applications are already available on-demand, however the lack of on-demand inter-carrier connectivity services remains a key barrier.
  • Amartus will demonstrate nBrace at MEF 19 both in the MEF PoC Showcase area and at the Amartus booth 514.
  • Amartus is a leading innovator in inter-provider business negotiation systems & network automation, providing both solutions and expert services to ICT providers & vendors.

Hemostasis Rapid Tests & Point of Care (POC) - Global Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 19, 2019

The "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.
  • This report provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage.
  • The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.
  • It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products.

Point of Care (PoC) Diagnostics Market To Reach USD 50.51 Billion by Billion By 2026 | Reports And Data

Retrieved on: 
Thursday, October 10, 2019

NEW YORK, Oct. 10, 2019 /PRNewswire/ -- According to the current analysis of Reports and Data, the global point of care (PoC) diagnostics market was valued at USD 23.98 billion in 2018 and is expected to reach USD 50.51 billion by the year 2026, at a CAGR of 9.6%.

Key Points: 
  • NEW YORK, Oct. 10, 2019 /PRNewswire/ -- According to the current analysis of Reports and Data, the global point of care (PoC) diagnostics market was valued at USD 23.98 billion in 2018 and is expected to reach USD 50.51 billion by the year 2026, at a CAGR of 9.6%.
  • The inception of near-patient, bedside or extra-laboratory testing, otherwise known as Point of Care (PoC) Diagnostics has revolutionized modern healthcare.
  • The primary technologies being used for PoC diagnostics include the confluence of bench-top analyzers as well as hand-held devices.
  • Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1507
    Technological advancements in field of point of care diagnostics is the key factor contributing to the market growth.

Point of Care (PoC) Diagnostics Market To Reach USD 50.51 Billion by Billion By 2026 | Reports And Data

Retrieved on: 
Thursday, October 10, 2019

NEW YORK, Oct. 10, 2019 /PRNewswire/ -- According to the current analysis of Reports and Data, the global point of care (PoC) diagnostics market was valued at USD 23.98 billion in 2018 and is expected to reach USD 50.51 billion by the year 2026, at a CAGR of 9.6%.

Key Points: 
  • NEW YORK, Oct. 10, 2019 /PRNewswire/ -- According to the current analysis of Reports and Data, the global point of care (PoC) diagnostics market was valued at USD 23.98 billion in 2018 and is expected to reach USD 50.51 billion by the year 2026, at a CAGR of 9.6%.
  • The inception of near-patient, bedside or extra-laboratory testing, otherwise known as Point of Care (PoC) Diagnostics has revolutionized modern healthcare.
  • The primary technologies being used for PoC diagnostics include the confluence of bench-top analyzers as well as hand-held devices.
  • Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1507
    Technological advancements in field of point of care diagnostics is the key factor contributing to the market growth.

Global Point of Care (POC) Diagnostics Market Trends 2017-2019, and CAGR Projections to 2023

Retrieved on: 
Thursday, October 10, 2019

Dublin, Oct. 10, 2019 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Dublin, Oct. 10, 2019 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The United States is the world's largest single market for diagnostic testing.
  • This study focuses on POC testing, which is one of the most active segments within the diagnostic industry.
  • The global POC testing market is led by Roche, Johnson & Johnson, Alere, Abbott, Siemens and Danaher.

Global POC Coagulation Testing Market 2019-2023| 6% CAGR Projection Over the Next Five Years | Technavio

Retrieved on: 
Wednesday, August 7, 2019
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20190807005318/en/
    Technavio has announced its latest market research report titled global POC coagulation testing market 2019-2023.
  • This global POC coagulation testing market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
  • Global POC Coagulation Testing Market: Automation in POC Coagulation Testing Products
    The POC coagulation testing market is witnessing the development of automated products.
  • Global POC coagulation testing Market: Segmentation Analysis
    This market research report segments the global POC coagulation testing market by end-user (hospitals and clinics, and home care), and geographic regions (North America, Europe, Asia, and ROW).

Sagentia Addresses 'Solutions for Sample Preparation at Point of Care' at AACC 2019

Retrieved on: 
Tuesday, August 6, 2019

The booth will showcase some of the world class products that Sagentia has helped develop and the technologies that underpin them.

Key Points: 
  • The booth will showcase some of the world class products that Sagentia has helped develop and the technologies that underpin them.
  • In addition, a must-attend event is a talk being delivered by Nick Collier, Sagentia Medical CTO, and Carl Hewett, Sagentia Senior Product Developer, entitled 'Solutions for Sample Preparation at Point of Care (PoC)' on Tuesday 6th August, at 18:00 in the Oceanside room, Hilton, Anaheim.
  • "As molecular diagnostics moves to Point of Care there is much focus on how lab-based processes are being adapted to the PoC setting," comments Nick Collier, CTO, Sagentia.
  • "In particular, one area that is often overlooked is sample preparation.

Quidel and Abbott Lead in Market for POC Cardiac Markers: Kalorama Report

Retrieved on: 
Tuesday, July 16, 2019

ARLINGTON, Va., July 16, 2019 /PRNewswire-PRWeb/ --Quidel is the market leader in point-of-care (POC) cardiac markers, according to a recent report from Kalorama Information.

Key Points: 
  • ARLINGTON, Va., July 16, 2019 /PRNewswire-PRWeb/ --Quidel is the market leader in point-of-care (POC) cardiac markers, according to a recent report from Kalorama Information.
  • The findings were reported in Kalorama Information's latest report, Worldwide Market for Point-of-Care (POC) Diagnostics .
  • Quidel is a market leader in rapid immunoassays and has significant exposure to the POC markets relative to its size and total revenue, according to the report.
  • Quidel acquired the assets of the Triage business from Alere when Alere was acquired by Abbott in October 2017.

Hytera Emphasises Itself as Professional and Private Wireless Communications Solution Supplier at CCW 2019

Retrieved on: 
Monday, June 24, 2019

After connecting with vertical customers for over 20 years worldwide, Hytera Communications Corporation Limited realized that only turnkey solutions could satisfy them rather than any single device.

Key Points: 
  • After connecting with vertical customers for over 20 years worldwide, Hytera Communications Corporation Limited realized that only turnkey solutions could satisfy them rather than any single device.
  • This is what we believe in and are doing in the global market, and Malaysia market as well.
  • Hyteras innovative convergent solution braces DMR, PDT, Tetra and LTE convergence, and private and public network convergence, in terms of terminals, system infrastructure and command and dispatch systems.
  • Hytera also showed their complete PoC (Push-to-Talk over cellular) solutions targeting at operators and commercial users, from PoC terminals to PoC platform.